1. Department of Medicine, Oncology Division, Stanford University, Stanford, CA;
2. Department of Immunology, Institute for Cancer Research, Oslo University Hospital and Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway;
3. Department of Microbiology & Immunology, Baxter Laboratory of Genetic Pharmacology, Stanford University, Stanford, CA;
4. Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN;
5. Lymphoma Immunotherapy Program, Mount Sinai School of Medicine, New York, NY;
6. Service d'Hématologie Clinique, Centre Hospitalier Universitaire de Rennes and Inserm U917, Université de Rennes 1, Rennes, France;
7. Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA;
8. Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA;
9. Cancer Clinic, Department of Pathology, Oslo University Hospital, Oslo, Norway; and
10. Cancer Clinic, Department of Oncology, Oslo University Hospital, Oslo, Norway